Dyameo develops single-use endoscopic probes for the instant detection of cancer cells.
Dyameo has raised $1.1M in total funding. The most recent round was Seed. The last funding was announced in November 2021.
Dyameo's investors include AQUITI Gestion, Medevice.
Dyameo is headquartered in Limoges, France.
Dyameo develops single-use endoscopic probes for the instant detection of cancer cells.
Dyameo is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Dyameo — Funding & Investors." VCBacked, November 22, 2021, https://www.vcbacked.co/company/dyameo. Accessed August 14, 2026.
VCBacked. (2021). Dyameo — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/dyameo
{{cite web |title=Dyameo — Funding & Investors |url=https://www.vcbacked.co/company/dyameo |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated